Pfizer's (PFE) COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study

Pfizer's (PFE) COVID Pill Best in Class, Will Put Pressure on Merck (MRK) and Regeneron (REGN) - Analyst

November 5, 2021 8:47 AM EDT

(Updated - November 5, 2021 8:54 AM EDT)

Earlier today, Pfizer Inc. (NYSE: PFE) announced its investigational novel COVID-19 oral antiviral candidate, PAXLOVID, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR study of non-hospitalized adult patients with COVID-19,... More

Airlines, Reopening Stocks Surge Following Data From Pfizer (PFE) Antiviral Covid Pill

November 5, 2021 7:25 AM EDT

Airlines, Reopening Stocks Surge Following Data From Pfizer (NYSE: PFE) Antiviral Covid Pill

American Airlines (NASDAQ: AAL) +4..8%United Airlines (NASDAQ: UAL) +3.8%Delta Air Lines (NYSE: DAL) +4.9%Southwest Airlines (NYSE: LUV) +3.9%Carnival Corp. (NYSE: CCL) +4.7%Royal Caribbean (NYSE: RCL) +4.8%Norwegian Cruise Line (NYSE: NCLH) +5.8%
... More

Pfizer (PFE) Surges 8%, Merck (MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data

November 5, 2021 6:49 AM EDT

Pfizer (NYSE: PFE) Surges 8%, Merck (NYSE: MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data

... More

Biden sets COVID-19 vaccine rules for businesses, prompting Republican backlash

November 4, 2021 8:50 AM EDT

By Nandita Bose, David Shepardson, Ahmed Aboulenein and Tom Hals

WASHINGTON (Reuters) -President Joe Biden will enforce a mandate that workers at U.S. companies with at least 100 employees be vaccinated against COVID-19 or be tested weekly starting Jan. 4, spurring legal challenges from Republican governors who say Biden is overstepping his authority.

Within hours governors from Florida, Iowa and Indiana had vowed to fight the new rule, arguing it infringes on individual freedom.

Despite growing political opposition, the delayed roll-out of the mandate offered a reprieve to businesses facing labor shortages during the holiday season. Biden's... More

Vaccines-at-work Mandate Rules Issued By Biden Administration - Bloomberg

November 4, 2021 8:45 AM EDT

Vaccines-at-work Mandate Rules Issued By Biden Administration - Bloomberg

... More

Pfizer (PFE) PT Raised to $44 at Mizuho Securities

November 4, 2021 6:36 AM EDT

Mizuho Securities analyst Vamil Divan raised the price target on Pfizer (NYSE: PFE) to $44.00 (from $43.00) while maintaining a Neutral rating.... More

Popular stocks with increasing volume: PFE GME BB UBER AAL HOOD BBBY

November 3, 2021 3:07 PM EDT

Popular stocks with increasing volume: PFE GME BB UBER AAL HOOD BBBY

... More

Pfizer (PFE) PT Raised to $46 at Wolfe Research

November 3, 2021 6:04 AM EDT

Wolfe Research analyst Tim Anderson raised the price target on Pfizer (NYSE: PFE) to $46.00 (from $41.00) while maintaining a Peerperform rating.... More

Pfizer (PFE) PT Raised to $44 at Barclays

November 3, 2021 4:35 AM EDT

Barclays analyst Carter Gould raised the price target on Pfizer (NYSE: PFE) to $44.00 (from $41.00) while maintaining a Equalweight rating.... More